Immunex (Global rights to Leukine)

Business Data, Corporate Office and Headquarter Address

About

Immunex (Global rights to Leukine) is Buildings and Property in United States that focus on immuno-stimulant drug business. They cover business area such as granulocyte-macrophage colony-stimulate factor, function, white blood cell, bone marrow transplantation, case, engraftment delay, blood stem cell transplantation, induction chemotherapy, old patient, acute myelogenous leukemia.

Business Type

Buildings and Property

Country

United States

Founded

-

Company Focus

Immuno-stimulant Drug

Website

-

Corporate Office and Headquarter Office address:

Boston, MA
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

granulocyte-macrophage colony-stimulate factorfunctionwhite blood cellbone marrow transplantationcaseengraftment delayblood stem cell transplantationinduction chemotherapyold patientacute myelogenous leukemia

* We use standard office opening hours in near Immunex (Global rights to Leukine)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Immunex (Global rights to Leukine) Frequently Asked Questions

What or who is Immunex (Global rights to Leukine)?

Immunex (Global Rights To Leukine) is Buildings and Property business from United States that founded in - ( years old in ), Immunex (Global rights to Leukine) business is focusing on Immuno-stimulant Drug.

Where is Immunex (Global rights to Leukine) headquarter and corporate office address?

Immunex (Global rights to Leukine) headquarter office and corporate office address is located in Boston, MA United States.

Where is Immunex (Global rights to Leukine) country origins?

Immunex (Global rights to Leukine) was founded in United States.

What is Immuno-stimulant Drug business focus on?

In , Immunex (Global rights to Leukine) is currently focus on immuno-stimulant drug sector.

Disclaimer: This website is not affiliated with Immunex (Global rights to Leukine), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.